SCHEMBL11722198

SCHEMBL11722198

O=C(Cl)c1cncc([N+](=O)[O-])c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.56
▸ TSHR P16473 2/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ MAPT P10636 4/20 0.42
▸ GAA P10253 2/20 0.42
▸ HPGD P15428 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ CES1 P23141 2/20 0.42
▸ CES2 O00748 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ CACNA1B Q00975 1/20 0.41
▸ APBA1 Q02410 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ F2 P00734 1/20 0.38
▸ PLAU P00749 1/20 0.38
▸ KLKB1 P03952 1/20 0.38
▸ ELANE P08246 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1607866 0.83 TP53 (0.55) ALDH1A1SMN1; SMN2CYP3A4MAPTGAA
SCHEMBL940807 0.83 TP53 (0.55) ALDH1A1SMN1; SMN2CYP3A4MAPTGAA
Hydrochloric Acid SCHEMBL11722776 0.81 TP53 (0.53) ALDH1A1SMN1; SMN2CYP3A4MAPTGAA
SCHEMBL6086071 0.81 SMN1; SMN2 (0.63) ALDH1A1TSHRSMN1; SMN2CYP3A4MAPT
Hydrochloric Acid SCHEMBL11722772 0.81 TP53 (0.53) ALDH1A1SMN1; SMN2CYP3A4MAPTGAA
SCHEMBL287220 0.81 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2CYP3A4MAPTGAA
SCHEMBL20524695 0.81 MAPT (0.49) ALDH1A1TSHRSMN1; SMN2CYP3A4MAPT
SCHEMBL11719928 0.80 KMT2A (0.51) ALDH1A1SMN1; SMN2CYP3A4MAPTGAA
SCHEMBL11725136 0.79 MAPT (0.54) ALDH1A1SMN1; SMN2CYP3A4MAPTGAA
SCHEMBL54880 0.78 ALDH1A1 (0.66) ALDH1A1TSHRSMN1; SMN2CYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9303044-B2 7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2016-04-05 — — US disclosed
US-20150050325-A1 ORGANIC COMPOUNDS THE ROCKEFELLER UNIVERSITY (US) 2015-02-19 — — US disclosed
US-4053608-A 3-NITROPYRIDINE CARBOXAMIDES, POULTRY FEED SANKYO COMPANY LIMITED (JA) 1977-10-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150050325-A1 ORGANIC COMPOUNDS VCAM1, ICAM1, PLAT ALDH1A1 426/4885TSHR 4812/4885SMN1; SMN2 337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback